Posted in | News | Nanobusiness

Nanotechnology Corporation CEO Delivers Keynote Address at American-Russian Business Council

Anatoly Chubais, CEO of the Russian Corporation of Nanotechnologies (RUSNANO), established in 2007 to enable Government policy in the field of Nanotechnology, gave a keynote address at the annual meeting of the American-Russian Business Council, which opened in San Francisco on October 21, 2010. Mr. Chubais told the group, “Russia is faced with creating an economy based on innovative growth. The country does not have another option. The choice is innovation or degradation. There is no other path.”

Describing the work that RUSNANO carries out, Mr. Chubais lingered for a time on the corporation’s international projects. He told the group that more than 160 applicants from abroad have made requests to RUSNANO for project cofinancing. Sixty of these have come from the United States, the largest contributor of international requests.

The Supervisory Council of the Russian Corporation of Nanotechnologies has already approved three projects from the United States—one each in nanomaterials, microelectronics, and medicine. Aggregate budgets for these projects are one billion dollars of which RUSNANO will cofinance $270 million.

Collaboration with the United States in innovation has fostered contact with leading U.S. venture funds, including two visits, in May and October 2010, to Russia from leaders of US top venture capital funds. RUSNANO participated in organizing those visits during which the parties held meetings that laid groundwork for 11 potential joint projects in clean energy, electronics, and biotechnology. They have aggregate budgets of $1.2 billion of which $400 million is in a joint venture capital fund.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.